HOMA-IR as a Screening Test in NAFLD
NCT04084925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-09-12
Summary
The aim of this study is to evaluate the role of HOMA-IR in diagnosis of NAFLD in patients with type 2 DM.
Conditions
- NAFLD
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Principal Investigators
-
Mohammed A Mashaheet, MD · Faculty of medicine Fayoum university
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2018-06-20
- Completion
- 2018-12-20
Countries
- Egypt
Study Locations
More Related Trials
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
NCT04435054 ·Status: COMPLETED ·Phase: NA
-
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
NCT07149571 ·Status: RECRUITING
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
NCT01324414 ·Status: COMPLETED
-
Liver Fibrosis and Steatosis in dm Non Invasive Evaluation
NCT05605717 ·Status: UNKNOWN
-
MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
NCT06492369 ·Status: COMPLETED
-
Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)
NCT01110577 ·Status: COMPLETED
-
Diagnosis of Fatty Pancreas by FibroScan
NCT07255989 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
Assessment of Fatty Liver With Thermo-acoustic Device
NCT04302051 ·Status: WITHDRAWN
-
Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages
NCT04241575 ·Status: COMPLETED ·Phase: NA
-
Prevalence of NAFLD in T1DM Patients
NCT06445361 ·Status: RECRUITING ·Phase: NA
-
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
NCT04553796 ·Status: UNKNOWN
-
Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy
NCT03612973 ·Status: COMPLETED ·Phase: NA
-
Determination of Insulin-stimulated Hepatic Glucose Uptake by PET-CT Measurements
NCT04938544 ·Status: UNKNOWN
-
Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients
NCT07175688 ·Status: COMPLETED
-
Hepatic Steatosis and Chronic Hepatitis B Virus
NCT05678582 ·Status: COMPLETED
-
Observational Study About Patients Diagnosed With NAFLD
NCT05625750 ·Status: RECRUITING
-
Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis
NCT03746210 ·Status: RECRUITING
-
A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
NCT05255978 ·Status: RECRUITING
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
NCT06225193 ·Status: RECRUITING
-
Splanchnic and Systemic VLDL-TG and FFA Balance
NCT04292977 ·Status: COMPLETED
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN